Pasithea Therapeutics Corp.
Pharmaceutical Preparations · MIAMI BEACH · FL
Moderate confidence (50%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Pasithea Therapeutics Corp. was delisted from its exchange (Sep 16, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Pasithea Therapeutics Corp. was delisted from its exchange
Sep 16, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001841330 Pasithea Therapeutics Corp. 001-40804 1111 Lincoln Road Suite 500 Miami Beach FL FLORIDA 33139 702-514-4174 warrants 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-09-16”
Pasithea Therapeutics Corp. received a delisting notice from its exchange
Aug 20, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on February 20, 2026, Pasithea Therapeutics Corp. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock, par value $0.0001 per share (the Common Stock ), for the prior 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for…”
Pasithea Therapeutics Corp. received a delisting notice from its exchange
Feb 20, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 20, 2026, Pasithea Therapeutics Corp. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Notice does not result in the immediate delisting of the Company s common stock f…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the tickers KTTAW and KTTA on Nasdaq.
- SEC CIK
- 0001841330
- Website
- —
- —
- Headquarters
- MIAMI BEACH, FL
- Also known as
- —
- Legal entities
- Pasithea Therapeutics Corp.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001841330 Pasithea Therapeutics Corp. 001-40804 1111 Lincoln Road Suite 500 Miami Beach FL FLORIDA 33139 702-514-4174 warrants 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-09-16
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
Pasithea Therapeutics Corp. — Pharmaceutical Preparations (SIC 2834) — MIAMI BEACH, FL
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 20, 2026, Pasithea Therapeutics Corp. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Notice does not result in the immediate delisting of the Company s common stock f…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on February 20, 2026, Pasithea Therapeutics Corp. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock, par value $0.0001 per share (the Common Stock ), for the prior 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share for…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:09 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.